Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/41038
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Galea, Monica | - |
dc.contributor.author | Zarb Adami, Maurice | - |
dc.date.accessioned | 2019-03-11T08:13:01Z | - |
dc.date.available | 2019-03-11T08:13:01Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Galea, M., & Zarb Adami, M. (2011). A pilot study to determine the cost of pharmaceutical drug treatment for chronic conditions prescribed in relation to patients' age. Journal of Euromed Pharmacy, 01, 24-29. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar//handle/123456789/41038 | - |
dc.description.abstract | Objective: To determine the age distribution of patients and the total drug cost. To establish the average cost per age group and identify factors that may influence cost. Method: A pilot study was conducted by selecting by convenience sampling a number of patients over 18 years who were registered in the Pharmacy of Your Choice scheme with a community pharmacy where the study was carried out. For each patient, type, frequency and cost of medication supplied were identified from treatment cards and from Government Health Procurement Services (GHPS). Key findings: Data was collected for 491 patients (aged between18-98 years) were 272 (55%) were females and 10% (n = 47) were institutionalised. Eight percent (n=395) were prescribed drugs for cardiovascular diseases which constituted 50% of the total drug expenditure. Daily cost per patient was one euro. Pearson correlation value (p<0.05) revealed a significant relationship between the increase in cost, unit doses and number of diseases with increasing age, between gender and different settings. Gender variation between drug categories was not significant (p>0.05). Conclusions: Cost of drug treatment is vital information that financing providers and policy makers require for the allocation of budgets. Findings suggest that populations are ageing, cost increases with age and that gender and setting influence the treatment being provided. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Department of Pharmacy & The Malta Pharmaceutical Association | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Drugs -- Prices -- Malta | en_GB |
dc.subject | Drug utilization -- Case studies | en_GB |
dc.title | A pilot study to determine the cost of pharmaceutical drug treatment for chronic conditions prescribed in relation to patients' age | en_GB |
dc.type | article | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.publication.title | Journal of Euromed Pharmacy | en_GB |
Appears in Collections: | Journal of Euromed Pharmacy : issue 01 : 2011 Journal of Euromed Pharmacy : issue 01 : 2011 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
A_pilot_study_to_determine_the_cost_of_pharmaceutical_drug_treatment_for_chronic_conditions_prescribed_in_relation_to_patients'_age_2011.pdf | 290.8 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.